Here we compared the effects of photon and proton therapy on the activation of anti-tumour immunogenicity markers including the nucleic acid sensing/IFNB1 axis and canonical NF-κB using multiple dose levels and a clinically relevant fractionation regimen. Here, IFNB1 is linked to neoplasm.